FdaApplication
NDA 211172
Identifiers
- fda_app_no: NDA211172
Properties
| Property | Value |
|---|---|
| applicant_name | AKCEA THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2018-10-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TEGSEDI | INOTERSEN SODIUM | EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) | SOLUTION;SUBCUTANEOUS |
1 product